E-MAIL: [email protected]
This guideline presents a process to assess and control elemental impurities in the drug product using the principles of risk management as described in ICH Q9. This process provides a platform ...
202025.08
FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis
By merging moisture protection with physical barriers, the pharmaceutical desiccant bottle performs dual duty: preserving drug in...
182025.08
In conclusion, the choice of cap for effervescent tablet packaging should be tailored to the specific needs of the medication. B...
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
Reserved Powered by
MAKE AN ENQUIRY
